A common drug could help restore limb function after spinal cord injury

Long-term treatment with gabapentin, a commonly prescribed drug for nerve pain, could help restore upper limb function after a spinal cord injury, new research in mice suggests.

In the study, mice treated with gabapentin regained roughly 60 percent of forelimb function in a skilled walking test, compared to restoration of approximately 30 percent of forelimb function in mice that received a placebo.

The drug blocks activity of a protein that has a key role in the growth process of axons, the long, slender extensions of nerve cell bodies that transmit messages. The protein stops axon growth at times when synapses form, allowing transmission of information to another nerve cell.

The research showed that gabapentin blocks the protein from putting on its brakes, which effectively allowed axons to grow longer after injury.

“There is some spontaneous recovery in untreated mice, but it’s never complete. The treated mice still have deficits, but they are significantly better,” said senior author Andrea Tedeschi, assistant professor of neuroscience at The Ohio State University.

“This research has translational implications because the drug is clinically approved and already prescribed to patients,” he said. “I think there’s enough evidence here to reconsider how we use this drug in the clinic. The implication of our finding may also impact other neurological conditions such as brain injury and stroke.”

The regained function in mice occurred after four months of treatment — the equivalent of about nine years in adult humans.

“We really have to consider that rebuilding neuronal circuits, especially in an adult central nervous system, takes time. But it can happen,” said Wenjing Sun, research assistant professor of neuroscience at Ohio State and first author of the publication.

The study is published in the Journal of Clinical Investigation.

The spinal cord injury in these mice is located near the top of the spine. Humans with this type of injury generally lose enough sensation and movement to require assistance with daily living tasks.

After receiving gabapentin for four months, the treated mice were better able to move across a horizontal ladder and spread their forelimb toes than untreated mice. When the researchers used a special technique to silence neurons in the repair pathway they had targeted, there was no difference in functional recovery between treated and untreated mice.

“Now we can comfortably say that whatever we see in terms of structural and functional alterations of this motor pathway is really meaningful in promoting recovery in these mice,” Tedeschi said.

Tedeschi noted that in this study, treatment with gabapentin occurred much earlier than is typical in human medicine, when it is prescribed to treat existing neuropathic pain and other neurological conditions.

“Gabapentin is given when the nervous system is already having issues associated with maladaptive plasticity that hinders normal function. We are giving it much, much earlier, when the nervous system may be more responsive to programming an adaptive repair process,” he said.

A retrospective study of European medical data published in 2017 showed that individuals who had received anticonvulsants — gabapentin or a similar drug — early after spinal cord injury regained motor function. It was not a clinical trial, but the analysis showed an association between taking a class of drugs called gabapentinoids and regaining muscle strength.

Plenty of questions remain: how and when to adjust the amount of gabapentin used for treatment, and whether the drug could be combined with other interventions used to promote repair of an injured spinal cord at chronic stages. But testing the effectiveness of the drug in larger animal models is a logical next step prior to embarking on clinical trials, Tedeschi said.

“With all the evidence and mechanistic insight we provide, I feel like we are in a better situation to start planning a more translational type of research,” he said. “It’s the right time to try.”

Tedeschi’s research focuses on neurons in the corticospinal tract — specifically motor neurons that carry signals from the central nervous system to the body telling muscles to move. These cells are particularly important in controlling voluntary movement, which is impaired in cervical spinal cord injuries modeled in the study.

This work builds upon the recent discovery of the regulatory role of a neuronal receptor called alpha2delta2 in controlling axon growth ability. Tedeschi and colleagues have determined that alpha2delta2 facilitates synapse formation by putting on the brake for axon growth, an essential step during the development of the central nervous system.

The researchers discovered in the current study that after a cervical spinal cord injury, affected motor neurons above the spine increased the expression of this receptor, interfering with axons’ ability to regrow. If axon repair doesn’t go as expected and neuronal circuits are reorganized improperly, individuals with spinal cord injury may experience uncontrolled movement and pain.

“When neuronal circuits need to be rebuilt after injury, we need to down-regulate the expression of the receptor so axons can re-engage in an active growth program. And we found that it’s doing exactly the opposite,” said Tedeschi, also a member of Ohio State’s Chronic Brain Injury Discovery Theme.

“Because this receptor can be pharmacologically blocked through administration of clinically approved drugs called gabapentinoids — for example, gabapentin and pregabalin — that’s a very powerful target that you can modulate as long as you take the drug.”

This research was funded by the Craig H. Neilsen Foundation, the Marina Romoli Onlus Association, the Ohio State University Neuroscience Research Institute, and grants from the National Institute of Neurological Disorders and the National Institutes of Health.

Share Button

Global carbon emissions growth slows, but hits record high

The runaway train that is climate change is about to blow past another milestone: global fossil-fuel carbon dioxide emissions will reach yet another record high. Driven by rising natural gas and oil consumption, levels of CO2 are expected to hit 37 billion tons this year, according to new estimates from the Global Carbon Project, an initiative led by Stanford University scientist Rob Jackson.

The findings are outlined in three new papers published in Earth System Science Data, Environmental Research Letters, and Nature Climate Change. Although the rate of emissions growth is slower than in the previous two years, the researchers warn emissions could increase through 2030 unless national energy, transportation and industry policies change dramatically.

“When the good news is that emissions growth is slower than last year, we need help,” said Jackson, a professor of Earth system science in Stanford’s School of Earth, Energy & Environmental Sciences (Stanford Earth). “When will emissions start to drop?”

The new projections come as international negotiators meet in Madrid for the 25th conference of the United Nations Framework Convention on Climate Change. Jackson and his colleagues make clear policymakers have their work cut out for them, estimating global carbon dioxide emissions from fossil fuel sources — which represent roughly 90 percent of all emissions from human activities — will grow a projected 0.6 percent over 2018 emissions. That compares to 2.1 percent growth a year earlier and 1.5 percent growth in 2017.

Glimmers of hope, such as the dramatic decline of coal use in the European Union and United States, are overshadowed by surging natural gas and oil use around the world, according to the researchers. Per capita emissions in affluent countries remain disproportionately high — a fact that further complicates the picture as developing countries seek greater prosperity through more natural-gas-fueled electricity and gasoline-powered vehicles and air travel.

“Emissions cuts in wealthier nations must outpace increases in poorer countries where access to energy is still needed,” said Pierre Friedlingstein, a mathematics professor at the University of Exeter and lead author of the Global Carbon Budget paper in Earth System Science Data.

Coal’s decline and natural gas’s rise

The group found that the U.S., E.U. and China account for more than half of all carbon dioxide emissions globally. While annual emissions are decreasing slowly in many industrialized regions, including the U.S., where they are down a projected 1.7 percent since last year, they are growing in many countries, including China, where they should jump 2.6 percent this year. About 40 percent of global carbon dioxide emissions were attributable to coal use, 34 percent from oil, 20 percent from natural gas, and the remaining 6 percent from cement production and other sources.

Although still a major factor in global emissions, coal has taken a hit, with global usage down 0.9 percent for the past year. In 2019, consumption of coal dropped 11 percent in the U.S. — down 50 percent from its peak in 2005 — displaced by cheaper natural gas, wind and solar power, as well as savings from energy efficiency. Coal use dropped a further 10 percent in the E.U. In China, which accounts for half of global coal use, growth slowed to 0.8 percent this year due in part to China’s economic downturn.

“Declining coal use in the U.S. and Europe is reducing emissions, creating jobs and saving lives through cleaner air,” said Jackson, who is also a senior fellow at the Stanford Woods Institute for the Environment and the Precourt Institute for Energy. “More consumers are demanding cheaper alternatives such as solar and wind power.”

Billed by some as a “bridge fuel” away from more pollutive energy sources, natural gas produces significantly fewer carbon dioxide emissions than oil or coal. Because of greater supply and cheaper prices, natural gas usage has surged, with an attendant 2.6 percent increase in carbon dioxide emissions for 2019. In fact, rising natural gas use accounts for 60 percent of fossil emissions growth in recent years.

The researchers warn that hopes for natural gas to be a bridge fuel can only come true with measures, such as carbon capture and storage, to mediate the fuel source’s emissions and a reduction in methane leakage from natural gas infrastructure.

Emissions responsibility

While some wealthier countries have made substantial progress in reducing overall emissions, per capita emissions in these countries remain stubbornly high. Around the world, the average person is responsible for about 4.8 tons of fossil carbon dioxide emissions per year. By comparison, the average person in the United States is responsible for more than three-and-a-half times that amount. Success stories, such as the E.U., where emissions have been declining about 1 percent per year are counterbalanced by the story of countries such as China, where per capita carbon dioxide emissions have grown to rival or even exceed those of the E.U.

Strong inequalities still exist, particularly in per capita oil use. U.S. oil consumption per person is 16 times greater than in India and six times greater than in China. Vehicle ownership is similarly skewed, with almost one motor vehicle per person in the United States but only one for every 40 people in India and 6 in China. A similar rate of car ownership in China or India as in the United States would put a billion new cars on the road in either country.

Light at the end of the tunnel?

To counterbalance increasing emissions, the researchers call for stronger national policies and global commitments to help institute carbon pricing, accelerate energy efficiency improvements, reduce energy consumption, deploy electric vehicles, ramp up carbon capture and storage technologies and replace fossil fuels with renewable sources.

More than 18 countries have found a way to expand their economies over the past decade while reducing carbon dioxide emissions, according to an earlier study that included co-authors affiliated with the Global Carbon Project. The countries include the United Kingdom and Denmark, which coupled stable or declining energy use with new renewable fuel capacity that displaced fossil fuel use.

“We need every arrow in our climate quiver,” Jackson said. “That means stricter fuel efficiency standards, stronger policy incentives for renewables, even dietary changes and carbon capture and storage technologies.”

Share Button

Diabetes drug has unexpected, broad implications for healthy aging

Metformin is the most commonly prescribed type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. In a collaborative effort, researchers from the Salk Institute, The Scripps Research Institute and Weill Cornell Medical College have used a novel technology to investigate why it functions so well. The findings, which identified a surprising number of biochemical “switches” for various cellular processes, could also explain why metformin has been shown to extend health span and life span in recent studies. The work was published in Cell Reports on December 3, 2019.

“These results provide us with new avenues to explore in order to understand how metformin works as a diabetes drug, along with its health-span-extending effects,” says Professor Reuben Shaw, co-corresponding author of the paper and the director of Salk’s NCI-designated Cancer Center. “These are pathways that neither we, nor anyone else, would have imagined.”

Previously, the only biochemical pathway that was known to be activated by metformin was the AMPK pathway, which Shaw discovered stalls cell growth and changes metabolism when nutrients are scarce, as can occur in cancer. But the scientists believed more pathways than AMPK might be involved.

The scientists developed a novel screening platform to examine kinases, the proteins that transfer phosphate groups, which are critical on/off switches in cells and can be rapidly flipped by metformin. Using this technology, the researchers were able to decode hundreds of regulatory “switch-flipping” events that could affect healthy aging.

“Being mentored by John Yates, one of the top mass spectrometry investigators in the world, and Reuben Shaw, an expert in the field of metabolism, enabled me to both develop and apply a novel technology to a critical biological question: What pathways are regulated by metformin in the liver?” says Ben Stein, first author and postdoctoral associate at Weill Cornell Medical College.

The results revealed that metformin turns on unexpected kinases and pathways, many independent of AMPK. Two of the activated kinases are called Protein Kinase D and MAPKAPK2. These kinases are poorly understood, but are known to have some relation to cellular stress, which could connect them to the health-span- and life-span-extending effects observed in other studies. In fact, metformin is currently being tested in multiple large-scale clinical trials as a health-span- and life-span-extending drug, but the mechanism for how metformin could affect health and aging has not been clear. The current study indicates that Protein Kinase D and MAPKAPK2 may be two players in providing these therapeutic effects, and identifies new targets and cellular processes regulated by AMPK that may also be critical to metformin’s beneficial effects.

“We never imagined these two kinases would have anything to do with metformin,” says Shaw, holder of the William R. Brody Chair. “The results broaden our understanding of how metformin induces a mild stress that triggers sensors to restore metabolic balance, explaining some of the benefits previously reported such as extended healthy aging in model organisms taking metformin. The big questions now are what targets of metformin can benefit the health of all individuals, not just type 2 diabetics.”

Next, the researchers plan to examine the new signaling pathways they discovered in more detail to better understand the beneficial effects of metformin.

Story Source:

Materials provided by Salk Institute. Note: Content may be edited for style and length.

Share Button

Samoa measles: Unvaccinated families told to hang red flag on door

The Pacific nation declares a state of emergency as 60 people die of measles.

Share Button

10 Self-Care Moves You Can Do at Your Desk

[brightcove:5624850626001 default]

Self care is all about taking care of your mind and body, so you feel less stress and more joy. Considering the hectic pace of the work world, most of us could benefit from more self-care during the workday—to crank up productivity, form stronger relationships with coworkers, and ace performance, says psychotherapist Suzie DeVaughn, owner of Self-Care Specialists in Wichita, Kansas.

If you already have a self-care routine at home or at the gym, then you know how it can make you feel happier and more in tune with yourself and your needs. So try incorporating these expert-backed easy moves into your workday as well. They'll help you shake off motivation killers like anxiety and stress and give you the tools to thrive from nine to five.

RELATED: Laverne Cox Has the Most Unique Self-Care Routine We've Ever Heard

Nourish yourself at lunch

With breakfast the most important meal of the day and dinner a time for reconnecting with loved ones, lunch tends to get short shrift. (They don't call it a sad desk salad for nothing, right?) Instead of wolfing down another on-the-fly veggie bowl or sandwich, make your midday meal more of an opportunity for nourishment. Pack or order foods you love that offer energizing protein and complex carbs, which can put you in a brighter mood and help you power through the afternoon. 

Check out a #funny site

Chase away stress by scrolling through the latest adorable animal viral video at @cutepetclub or watching a Saturday Night Live clip on YouTube you missed over the weekend. Laughing can prompt the release of the feel-good hormones endorphins and in turn make you feel more relaxed and revived. Even a few minutes in the break room with a coworker whose stories always crack you up will do the trick. 

Get up, stretch, and move

Stretch your arms and legs at your desk, do laps around the office, walk up and down the stairs, or take on some other activity that allows you to move your body. “When we start to feel our body signaling that we need a break, stepping out of your workspace for 5 to 10 minutes can help shift perspective and gain mental clarity,” says DeVaughn. “Running quick errands, going to make coffee or tea, or visiting with a co-worker are very helpful for rejuvenation.”

If you can get outside at some point during your workday, go for it: A 2017 study echoed previous research, finding that exposure to sounds found in nature has a soothing effect on the heart and brain.

Calm yourself with essential oils

Lavender, wild orange, and bergamot therapeutic-grade essential oils can relax and uplift you, says Krista-Lynn Landolfi, life coach and self-care specialist. Hiding a small stash of these in your desk drawer and occasionally dousing some on a cotton ball you can sniff will help revive your spirits without disturbing others sitting next to you. (But ask your deskmates if they have a hypersensitivity or allergy to these oils before you use them, just in case.)

Declutter and decorate 

A messy environment can intensify the tension and anxiety you already feel, says DeVaughn. No need to be a super organized neat freak if that's not your natural style. And yep, today's open-concept workplaces don't give even high-up employees much room to personalize. But take some time every week to organize your workspace and decorate it with family or pet photos, artwork that resonates with you, or quotes that inspire you. 

RELATED: 15 Ways to Add Self-Care to Your Workout Routine

Snack smartly

Vending machine runs are convenient, but you know that diet soda and sweet treats aren't exactly the best snack choices when you're racing against a deadline or feeling overwhelmed by a report. “When people are filling themselves with caffeine and sugar, it's going to give them a frenetic energy and create an ultimate crash,” explains Landolfi. Avoid that by opting for high protein nuts, filling air-popped popcorn, or a healthy smoothie.

RELATED: What Is High-Functioning Anxiety–and Could You Have It?

Repeat an inspiring mantra

The way we talk to ourselves shapes our performance and attitude. It's a good reason to come up with a go-to saying or a list of affirmations to recite out loud (or quietly to yourself) when you’re feeling doubtful or need a confidence boost, suggests DeVaughn. “I am the Beyoncé of this office" has a powerful ring to it, as does “I will succeed on this project with ease."

Take 3 deep breaths

You've heard that inhaling deeply can help energize and calm you. But Landolfi is a fan of a breathing exercise called "three to be free" breathing. Three times a day, stop what you're doing and take three deep breaths to free the tension, stress, and worry that has been build throughout the workday, she says. What makes this self-care move so good for work is that you can do it discreetly while you're sitting at your desk, and even your closest cubicle neighbor won't be disturbed.

RELATED: 9 Self-Care Gifts You Can Buy Yourself on Amazon

Speak out in a meeting

Doing something bold—writing a memo outlining your concerns over a new project, for example, or volunteering to take on a client who you know will challenge you—can put you back on your A game at the office. Why's that? Accomplishing something that you once feared can give you the adrenaline rush that you need to finish the day strong, says Landolfi. You'll feel more a part of your team and more invested in your work.

Pat yourself on the back

Take stock of what you've accomplished on the job once a week or so—and congratulate yourself for your efforts and anything you've done to boost the bottom line or improve performance. Reminding yourself of your contributions gives you a psychological boost and helps you feel more positive, which is the ultimate goal of self care.

To get our best wellness tips delivered to you inbox, sign up for the Healthy Living newsletter

Share Button

Miroslava Duma Reveals She Has Rare Lung Disease: ‘I Was Given 7 Months to Live’

Miroslava Duma has let her 1.6 million Instagram followers into a pretty major secret: she has been battling a rare lung disease. In a lengthy post on Sunday, she revealed that she was given just 7 months to live when she was diagnosed earlier this year.

“It was crazy scary then, but looking back, I realise that the past few months of recovery were possibly the happiest months of my entire life,” the fashion influencer and businesswoman wrote alongside a photograph of herself.

In the US, a rare disease is defined by the National Institutes of Health Office of Rare Diseases as one that affects fewer than 200,000 people; however, it is estimated that at least 1 to 2 million Americans suffer from rare lung diseases. It’s not clear what specific disease Duma has (or if she still has it), what treatment she has received, or when exactly she was diagnosed.

RELATED: These 3 Women Were Each Diagnosed With Advanced Lung Cancer—Even Though They Never Smoked

What is clear from her Instagram post is that the experience has been life-changing.

“I suddenly stopped running the marathon and realised how much I love life, how beautiful our world is and how much I want to stay here—with the people I love,” wrote the 34-year-old mom of three, who is married to fellow entrepreneur Aleksey Mikheev. “For the first time in my life, I saw the bright blue of skies. And the beautiful green of trees. As if I had lived on a different planet before. I wake up happy, just because I can spend one more day here.”

Duma went on to say that she has shifted her mentality and is no longer concerned about external validation. “My entire life I was seeking approval and obsessing over ‘likes’ both in physical and virtual worlds, without realising that I actually had to learn how to ‘like’ myself first,” she wrote. “Success to me today is not measured by external indicators anymore, but by what’s inside. It is measured by my own health, and the health of those I love.”

RELATED: 7 Causes of Lung Cancer in Nonsmokers

She believes her busy, high-pressure lifestyle was partly to blame for her poor health. “Years of self-criticism and doubt, stress, dieting, physically, mentally and emotionally pushing and pushing myself got my immune system to collapse and I had made myself fatally sick,” she shared. “I now realise that these past months were almost the most creative months of my entire 34 years."

She finished the post by thanking the “wonderful people” in her life, adding, “I love you with all of my heart (and my lungs).”

RELATED: This Woman Thought She Had Pneumonia—but It Turned Out to Be Stage 4 Lung Cancer

Duma was a regular on the fashion scene in the early 2000s, regularly photographed at New York and Paris Fashion Weeks. She served as project director at Harper’s Bazaar and has also freelanced for the Russian editions of Vogue, Forbes Woman and Glamour.

In 2011, she founded Buro 24/7, a website devoted to art, film, fashion, and music, and in 2017, she founded Future Tech Lab, an investment and technology company.

To get our top stories delivered to your inbox, sign up for the Healthy Living newsletter

Share Button

Cambridge baby loss charity Petals reinstates hospital counselling

Petals suspended counselling at the Rosie Hospital in Cambridge in September in an NHS funding row.

Share Button

Health24.com | Nasal swab could help gauge smokers’ odds for lung cancer

Could a person’s risk for lung cancer someday be determined with a quick swab of the nose?

If the preliminary findings of a new study are any indication, it’s a distinct possibility.

Not a screening tool

The experimental nasal swab relies on the fact that most lung cancer patients are current and former smokers. It’s meant to be a non-invasive means of separating high-risk patients from low-risk patients, by spotting signs of gene damage produced by long-term exposure to cigarette smoke.

“[But] this is not a screening tool,” stressed study author Dr. Carla Lamb, director of interventional pulmonology at Lahey Hospital and Medical Center in Burlington, Massachusetts.

Instead the swab’s purpose is “to help us determine which [suspicious] lung nodules require more invasive evaluations”. The overriding goal, she said, is “to help guide that decision-making”.

And that’s a useful goal, said Dr Norman Edelman, senior medical adviser for the American Lung Association.

“The [standard] method used for early detection is the low-radiation-dose CT scan,” noted Edelman, who was not part of the study. “A major problem with this method is that it’s often difficult to decide whether an abnormality it picks up is or is not cancer.”

The study team made the same point, noting that the vast majority of the roughly two million lung nodules identified every year in the United States turn out to be benign.

Rigorous genetic testing

But in the absence of foolproof non-invasive tools, doctors are often left to make initial best guesses based on “clues and clinical judgment”, explained Edelman.

Lamb noted, “This uncertainty can lead to either unnecessary invasive diagnostic procedures or delay in diagnosis and treatment.”

So, with funding from the swab test’s manufacturer (Veracyte, a genomic diagnostics company based in San Francisco), the team set out to assess the test’s effectiveness among a pool of 261 patients.

All had previously undergone CT scans, and those scans had unearthed potentially problematic lung nodules. Further testing later confirmed which patients truly had lung cancer and which didn’t. But while the swab investigation was underway, no one on the study team knew the definitive results.

After using the swab to brush across each patient’s nasal passage, the collected contents were subjected to rigorous genetic testing.

If the test unearthed signs of smoke-induced damage, the patient would be classified as “high-risk”. That did not necessarily mean that he or she had lung cancer. But it meant that more invasive testing was warranted, along the lines of tissue excision and analysis (biopsy). Only invasive follow-up testing – not the swab test alone – could confirm lung cancer.

Test performed ‘consistently’

On the other hand, if the test found no signs of damage, then a patient could be deemed “low-risk”. He or she would then be spared the ordeal of more invasive exams, in favour of routine CT scans and monitoring.

In the end, the swab test correctly classified as low-risk more than 40% of the cancer-free patients. Similarly, the swab test also accurately classified as high-risk 40% of those patients who actually had cancer.

The team said that the test performed “consistently” across all lung nodule sizes, nodule locations and cancer types and stages.

And the results “had a very high specificity”, said Lamb, meaning that patients deemed high-risk and sent for further tests were very likely to have lung cancer.

The study findings suggest that “the test developed by these investigators should reduce the uncertainty as to whether an abnormality is benign or malignant in about 40% of people scanned,” Edelman said.

“And this may well be useful in the decision-making process,” he agreed. But he cautioned that as it stands, “the test is not specific enough to replace all of the other tools doctors now use to determine whether an abnormality is malignant or not.”

Preliminary findings

For the time being, Edelman said, “the best advice to former and current smokers is to check with your doctor to see if you are eligible for CT scan screening. It could save your life.”

The findings – which are considered preliminary and have not yet undergone peer review – were presented this week at the American College of Chest Physicians (CHEST) annual meeting, in New Orleans.

Image credit: iStock

Share Button

Formation of ducts connecting digestive organs in zebrafish

A specialised system of ducts transports bile and enzymes from the liver and pancreas to the intestine. In a new study, researchers from the University of Copenhagen have shown how this ductal system is formed. The new knowledge can help understanding how congenital diseases in that part of the body arise.

The body’s liver, gallbladder and pancreas are connected by a specialised system of ducts, the so-called hepatopancreatic ductal system, that are leading to the intestine. Bile, digestive enzymes and other secretions flow through the ducts, which are therefore essential for enabling the digestion of food and the absorption of nutrients.

Now, researchers from the University of Copenhagen have investigated how this ductal system forms. The results have been published in the scientific journal Nature Communications.

The new findings may help to better understand rare diseases in the ductal system, such as biliary atresia. This is a disease in children where the ductal network is not properly developed, which can in some cases lead to severe liver damage.

‘We know very little about diseases such as biliary atresia, where the ducts are blocked or completely absent. In order to understand how and why these diseases occur, it is important to find out how the entire ductal system forms during development,’ says Associate Professor and co-author of the study Elke Ober, Novo Nordisk Foundation Center for Stem Cell Biology (DanStem).

‘In the study, we show that the ductal system is formed in a multi-step process, with different cell rearrangement and remodelling phases taking place until the ducts are open and fully developed. We have also found an important group of genes that control part of this process,’ says co-author and postdoc Ilcim Thestrup, who performed her PhD thesis at DanStem.

The researchers have characterised the formation of the ductal system in zebrafish. The system is formed during embryonic stages. In humans, this takes several weeks, while in zebrafish the ductal system develops in about 48 hours.

Zebrafish resemble humans in many ways: Organ systems, functional cell types and signals controlling developmental processes are highly similar. This together with the fast embryonic development, are the reason why Elke Ober’s research group chose to use zebrafish for this study.

In addition to experiments with zebrafish, the researchers examined human tissue samples to investigate if the group of genes, which they found in zebrafish, is also expressed in humans.

‘We found a group of genes called EphB and EphrinB in the zebrafish, which instruct part of the development of the ductal system. We have shown that this group is also expressed in humans. This indicates that these genes may play the same or a similar role in the formation of these ducts in humans and if misregulated, they may potentially cause ductal diseases,’ says Elke Ober.

Share Button

How does language emerge?

How the languages of the world emerged is largely a mystery. Considering that it might have taken millennia, it is intriguing to see how deaf people can create novel sign languages spontaneously. Observations have shown that when deaf strangers are brought together in a community, they come up with their own sign language in a considerably short amount of time. The most famous example of this is Nicaraguan Sign Language, which emerged in the 1980s. Interestingly, children played an important role in the development of these novel languages. However, how exactly this happened has not been documented, as Manuel Bohn describes: “We know relatively little about how social interaction becomes language. This is where our new study comes in.”

In a series of studies, researchers at the Leipzig Research Centre for Early Childhood Development and the Max Planck Institute for Evolutionary Anthropology attempted to recreate exactly this process. The idea had been around for quite some time, says Gregor Kachel. But there was a problem: how to make children communicate with each other without them reverting to talking to each other? The solution came up in Skype conversations between the two researchers from Germany and their colleague Michael Tomasello in the US. In the study, children were invited to stay in two different rooms and a Skype connection was established between them. After a brief familiarization with the set-up, the researchers sneakily turned off the sound and watched as the children found new ways of communicating that go beyond spoken language.

The children’s task was to describe an image with different motifs in a coordination game. With concrete things — like a hammer or a fork — children quickly found a solution by imitating the corresponding action (e.g. eating) in a gesture. But the researchers repeatedly challenged the children with new, more abstract pictures. For example, they introduced a white sheet of paper as a picture. The depicted “nothing” is difficult to imitate. Kachel describes how two children nevertheless mastered this task: “The sender first tried all sorts of different gestures, but her partner let her know that she did not know what was meant. Suddenly our sender pulled her T-shirt to the side and pointed to a white dot on her coloured T-shirt. The two had a real breakthrough: of course! White! Like the white paper! Later, when the roles were switched, the recipient didn’t have a white spot on her T-shirt, but she nevertheless took the same approach: she pulled her T-shirt to the side and pointed to it. Immediately her partner knew what to do.” Within a very short time, the two had established a sign for an abstract concept. In the course of the study, the images to be depicted became more and more complex, which was also reflected in the gestures that the children produced. In order to communicate, for example, an interaction between two animals, children invented separate gestures for actors and actions and began to combine them — thus creating a kind of small local grammar.

How does a language emerge? Based on the present study, the following steps appear plausible: first, people create reference to actions and objects via signs that resemble things. The prerequisite for this is a common ground of experience between interaction partners. Partners also coordinate by imitating each other such that they use the same signs for the same things. The signs thus gain interpersonal and eventually conventional meaning. Over time, the relationships between the signs and things become more abstract and the meaning of the individual signs more specific. Grammatical structures are gradually introduced when there is a need to communicate more complex facts. However, the most remarkable aspect of the current studies is that these processes can be observed under controlled circumstances and within 30 minutes.

The studies demonstrate that communication cannot be reduced to words alone. When there is no way to use conventional spoken language, people find other ways to get their message across. This phenomenon forms the basis for the development of new languages. The study by Manuel Bohn, Gregor Kachel and Michael Tomasello shows what the first steps in the development of a new language could look like. According to Bohn, however, numerous new questions arise at this point: “It would be very interesting to see how the newly invented communication systems change over time, for example when they are passed on to new ‘generations’ of users. There is evidence that language becomes more systematic when passed on.”

Story Source:

Materials provided by Max Planck Institute for Evolutionary Anthropology. Note: Content may be edited for style and length.

Share Button